A practical multigram metal free synthesis of isoxazole-containing building blocks from commercially available amino acids was elaborated. The key reaction was a regioselective [3 + 2]-cycloaddition of in situ generated nitrile oxides with alkynes/enamines. The obtained building blocks were used in the preparation of bioactive compounds and peptidomimetics.
Introduction
The isoxazole core is a structural element in many commercial pharmaceuticals (Fig. 1 ). The range of biological activities of the isoxazole-containing drugs is broad: analgesic, 1 anti-inam-matory, neuroprotective, 9 and HIV-inhibitory agents. 10 In this context, the development of practical methods towards isoxazole-based building blocks from common cheap starting materials is truly desirable.
Nitrile oxides are useful intermediates towards the synthesis of a wide plethora of isoxazole-based architectures. 11a-h However; most of these methods either utilize toxic metals or hypervalent iodine compounds 11h which in turn, are not environmentally friendly. At the same time, there are just a few known reports dealing with metal-free conditions and most common are based on the use of triethylamine 12a-b and sodium perchlorate/triethylamine.
12c Therefore, the development of metal-free protocols towards the synthesis of compounds bearing isoxazole core is of particular interest.
12d,e
The use of amino acids 13a-h in construction of isoxazolecontaining compounds has been known before. However, these reports, dealt with the specic amino acids, and the studies have not been performed systematically on large variety of substrates. Taking into account the need of exploration of metal-free protocols as well as search for easily available substrates, herein we would like to elaborate on a general practical multigram metal-free synthesis of isoxazole-core building blocks starting from commonly available and diverse a-, b-and g-amino acids.
Results and discussion Synthesis 1. Synthesis of chloroximes from amino acids. The initial synthesis step was reduction of the amino acid carboxyl-groups in a number of N-Boc protected amino acids. Resulting N-Boc amino alcohols were subsequently oxidized into the corresponding aldehydes (Table 1) . These aldehydes formed oximes upon treatment with hydroxylamine under mildly basic conditions (sodium hydrogen carbonate). The oximes were then treated with N-chlorosuccinimide under acidic conditions to afford the target N-Boc protected chloroximes 1-7 in good yields. The products were white powders that could be stored at room temperature for at least several months as exemplied in Table 1. 2. Synthesis of N-Boc aminoisoxazoles via [3 + 2]-cycloaddition. It is worth mentioning that our methodology for the synthesis of variety isoxazoles is known and here we would just mention some selected examples where the similar conditions like base or reaction temperatures were applied. Johnson et al. reported on the regioselective synthesis of 3,4-disubstituted isoxazoles between enolsilanes and nitrile oxides.
14 In the same vein, the Zhu group and later Wang and co-workers reported on the synthesis of 3,4-disubstituted isoxazoles in high yields.
15a,b The key point of the reported protocols was the reaction of in situ generated enamines from corresponding ketones or b-keto esters and nitrile oxides. Caddick and co-workers reported and interesting strategy towards the synthesis of 3,5-disubstituted isoxazoles bearing sulfonamide group at the 5-position. 16 Later the Shibata group developed the strategy for the synthesis of isoxazole triones. 17 Hamme et al. reported on the synthesis of 3,5-disubstituted isoxazoles with electron withdrawing group at the 5-position by the reaction of 1,1-disubstituted bromoalkenes with nitrile oxides.
18a,b Last but not least Schmidt and co-workers reported on the regioselective synthesis of 4-triuorosubstituted isoxazoles in good yields. 19 All the aforementioned methods avoided the usage of metalmediated reactions which prompted us to follow the similar conditions in order to synthesize a large panel of aminoisoxazoles in large scale.
In our case, synthesis of isoxazoles from the corresponding in situ generated nitrile oxides and alkynes/enamines was analogous to the mentioned above methods. Namely, treatment of chloroximes 1-7 with a mild base (sodium hydrogen carbonate or triethylamine) at either the room temperature or at 0 C led to generation of corresponding nitrile oxides (Table 2 ). Subsequent addition of enamines 8-10 (1.2 eq.) to these in situ generated nitrile oxides lead to [3 + 2] -cycloaddition intermediates that readily eliminated dimethylamine to give the 3,4-disubstituted isoxazoles in a regioselective fashion as previously reported with push-pull enamines ( Table 2, A) . 20 In contrast, terminal alkynes 11, 12 afforded a mixture of 3,4-/3,5-isomers $30/70 when reaction was performed at the room temperature.
21 Nevertheless, the same reaction at 0 C exhibited an improved regioselectivity of $10/90, and the major 3,5-disubstituted isomers were easily isolated by column chromatography.
22
While the above described [3 + 2] cycloaddition reactions were performed in ethyl acetate the synthesis also worked well in tetrahydrofuran, dichloromethane, dimethoxymethane or chloroform, though with compromised regioselectivity. At the same time synthesis of isoxazoles in water as environmentally benign solvent is of high interest.
23 It is also worth mentioning, that these reactions were performed under obligatory high dilution -substrate/solvent ¼ 1/10 (wt/v) -otherwise formation of side furoxans was observed.
24
As the result we obtained a variety of N-Boc aminoisoxazoles initially starting from amino acids, and the synthetic approach was scalable such that up to 50 g of a product (Boc-6-H) was obtained in a single synthesis run.
3. Synthesis of isoxazole-containing amines and amino acids. We also made several forays toward the cleavage of TMS-group utilizing K 2 CO 3 or triuoroacetic acid (TFA) as TMS-scavengers, 25 but unfortunately in our case the described procedure was not that efficient, furnishing the desired products in moderate yields. Moreover, attempts to cleave TMS-group with 4 M HCl in dioxane were also not optimal giving low yields. Though, these forays were not successful, it allowed us to improve our tactics. As a result, we found that cleavage of the TMS-group from the isoxazole core was easily achieved by treatment with catalytic amounts of KHF 2 in methanol-water mixture. Resulting 3-substituted isoxazoles were obtained in excellent yields (Table 3) .
As next, cleavage of N-Boc group from all compounds was performed under acidic conditions to afford the target building blocks -aminoisoxazoles (Table 4) .
Carboxymethyl-substituted isoxazoles were saponicated with sodium hydroxide in methanol to afford corresponding free amino acids in good yields (Table 5) .
The structures of two nal compounds were conrmed by X-ray analysis (Fig. 2) . Interestingly, the structure of Boc-4A-COMe indicates a repulsion occurring between the carbamate carbonyl oxygen and the isoxazole nitrogen, similar to what has been recently reported for analogous structures with 1,3-oxa/ thiazine in place of the isoxasole. 
Practical applications
Aer having established a practical general synthetic protocol towards isoxazole-containing building blocks, we also aimed to demonstrate applicability of the synthesized structures in other chemical areas.
1. Synthesis of a drug candidate. ABT-418 is a known nootropic agent. 27a Recently, chemists at Abbott Laboratories synthesized its bioisostere 16 in four steps and 7.3% total yield starting from 4 and 2-bromopropene.
27b Herein, we have developed an alternative approach to afford compound 16 (Scheme 1). First, [3 + 2] -cycloaddition between allylbromide and nitrile oxide generated from chloroxine 4 gave isoxazoline 13 in 95% yield. Next, elimination of hydrogen bromide under basic conditions gave isoxazole 14. Cleavage of the N-Boc group produced free amine 15, which was then subjected to reductive amination with aqueous formaldehyde to afford the target product 16 in gram quantities. The overall yield of the synthesis was 55% over 5 steps.
2. Synthesis of peptidomimetics. We also envisioned that chiral aminoisoxazoles could be used to prepare conformationally restricted peptidomimetics.
28 In this case the heterocyclic fragment will act as a rigid peptide bond substitute 29 (Scheme 2).
In addition, isomeric oxazoles and thiazoles are common in the backbones 30 of various ribosomally synthesized and posttranslationally modied peptides. 31 Construction of an azole ring is generally afforded in nature by cyclization of serine or threonine side chain on the downstream amide bond. [32] [33] [34] Total synthesis of respective peptidomimetics has been developed in order to provide naturally occurring antimicrobial agents or toxins as well as their chemically modied analogues. 35, 36 Though, oxa/thiazole to isoxazole mutations have not been explored. Therefore, next we attempted the synthesis of isoxazole-containing peptidomimetics by solid phase peptide synthesis (SPPS) in order to highlight this opportunity.
Initially we synthesized the Fmoc-protected amino acid Fmoc-AlaIso-OH (17) (Scheme 3). Peptide chains were grown on Rink-amide resin, and TBTU/HOBt/DIPEA system was used for coupling. Only in the case of Ac-Leu-AlaIso-Val-NH 2 (18) we observed minor degree of epimerization (#15%), whereas in Ac- Table 2 The synthesis of N-Boc aminoisoxazoles via [3 + 2] -cycloaddition a Et 3 N was used instead of NaHCO 3 to generate the nitrile oxide, 5 eq. of 12 were used.
Leu-Val-AlaIso-NH 2 (19) no racemization was observed. 37 In addition, no degradation was found aer cleavage from the resin upon treatment with TFA/TIS. Generally the amino acid Fmoc-AlaIso-OH turned out to be compatible with the standard SPPS, allowing synthesis and isolation of both target peptides by conventional methods.
38 Table 3 Cleavage of TMS-group from the isoxazole ring 
Conclusions
We have developed a general metal-free practical protocol towards isoxazole-containing building blocks starting from commonly available a-, b-and g-amino acids. The target products were obtained in up to 50 g scale. The high potential of the developed method was demonstrated by synthesis of compound 16 -bioisostere of the known nootropic agent ABT-418, -and preparation of isoxazole-containing peptidomimetics 18, 19 by solid phase peptide synthesis.
Experimental section

General
All reagents were available from Enamine Ltd. Solvents were puried according to standard procedures. When organic solutions were concentrated under reduced pressure, 35-40 C bath temperature was used. Column chromatography was performed 
Synthesis of 3,4-disubstituted isoxazoles, representative procedure
Methyl 3-(((tert-butoxycarbonyl)amino)methyl)isoxazole-4-carboxylate (Boc-1A-CO 2 Me). A 250 mL round bottomed ask was charged with a magnetic stirrer, corresponding chloroxime 1 (2 g, 9.6 mmol) and EtOAc (20 mL). To the resulting vigorously stirred homogeneous solution (E)-methyl 3-(dimethylamino) acrylate 8 (1.48 g, 11.5 mmol) was added followed by addition of NaHCO 3 (1.6 g, 19.2 mmol) at the ambient temperature. The resulting mixture was stirred overnight. The progress of the reaction was monitored by NMR spectroscopy. Aer the reaction was complete, the organic phase was washed with 10% NaHSO 4(aq) (3 Â 5 mL), 10% K 2 CO 3(aq) (2 Â 5 mL) and brine (1 Â 5 mL). Organic phase was dried over anhydrous Na 2 SO 4 . The resulting mixture was ltered through a silicagel pad and concentrated to yield Boc-1A-CO 2 Me (95%, 2.3 g) as a beige powder, mp 65 C. 1 H NMR (500 MHz, DMSO-d 6 ): d 9.59 (s, 1H, isoxaz), 7.24 (brs, 1H, NH), 4.41 (d, 2H, CH 2 ), 3.80 (s, 3H, OCH 3 ), 1.39 (s, 9H, CH 3 -Boc).
13
C NMR (125 MHz, DMSO-d 6 ): d 164. 9, 161.1, 160.0, 155.4, 111.9, 78.2, 51.9, 35.9, 28 
Synthesis of 3,5-disubstituted isoxazoles, representative procedure
Methyl 3-(((tert-butoxycarbonyl)amino)methyl)isoxazole-5-carboxylate (Boc-1B-CO 2 Me). A 250 mL round bottomed ask was charged with a magnetic stirrer, corresponding chloroxime 1 (2 g, 9.6 mmol) and EtOAc (20 mL). Then, the resulting vigorously stirred homogeneous solution was cooled to À5-0 C and methyl propiolate (0.9 mL, 10.1 mmol) was added followed by addition of NaHCO 3 (1.6 g, 19.2 mmol) (in case of reaction 7 (2 g, 7.6 mmol) with ethynyltrimethylsilane 12 (5.4 mL, 38 mmol) dropwise addition of Et 3 N (1.6 mL, 11.5 mmol) as a solution in EtOAc (100 mL) was required). The resulting mixture was stirred overnight. The progress of the reaction was monitored by NMR spectroscopy. Work-up was done by simple ltration through silica pad, then the resulting solution was concentrated and dried in vacuo to yield the corresponding product Boc-1B-CO Representative procedure for cleavage of tert-butyloxycarbonyl group 1-(3-(Aminomethyl)isoxazol-4-yl)ethan-1-one hydrochloride (1A-COMe$HCl). A 250 mL round bottomed ask was charged with a magnetic stirrer, corresponding Boc-protected isoxazole Boc-1A-COMe (2.5 g, 9.8 mmol) and EtOAc (25 mL). The ask was submerged into an ice cooling bath; and to the vigorously stirred homogeneous solution equimolar ratio of MeOH (1.05 eq.) was added followed by dropwise addition of AcCl (1.05 eq.). As the result white precipitate was formed. Aer the reaction was complete (NMR control) resulting solid was ltered and washed with cold EtOAc and recrystallized from MeCN (if it was necessary) affording 1A-COMe$HCl as a white powder. In case of EWG ¼ CO 2 Me-group AcCl (1.05 eq.) in MeOH was used.
1A , 5.14; N, 15.86. Found: C, 40.25; H, 5.33; N, 15.96 .
Representative procedure for the hydrolysis of isoxazole-based esters 3-(((tert-Butoxycarbonyl)amino)methyl)isoxazole-4-carboxylic acid (Boc-1A-CO 2 H). A 250 mL round bottomed ask was charged with a magnetic stirrer, corresponding isoxazole (Boc-1A-CO 2 Me, 2 g, 7.8 mmol) and MeOH (18 mL). Next, the ask was submerged into an ice cooling bath and to the resulting vigorously stirred homogeneous solution 2 equiv. of 10% NaOH (aq) was added dropwise. Aer the NMR control indicated the reaction completion (10-24 h), the solution was concentrated in vacuo. HCl (aq) , or NaHSO 4(aq) , was added dropwise until pH ¼ 3 was reached and solid NaCl was added until the resulting solution become saturated. The product was extracted by EtOAc (3 Â 20 mL). Combined organic fractions were dried over anhydrous MgSO 4 , concentrated and dried in vacuo yielding Boc-1A-CO 2 H as a white powder, (95%, 1.8 g), mp 129- H, 5.83; N, 11.56. Found: C, 49.38; H, 5.66; N, 11.43 .
Representative procedure for the for the synthesis of 3-substituted isoxazoles tert-Butyl (isoxazol-3-ylmethyl)carbamate (Boc-1-H). A round bottomed ask (100 mL) was charged with a magnetic stirrer, substrate Boc-1-H-TMS (5. 5 g, 20.3 mmol) and MeOH (25 mL). KHF 2 5 mol% (80 mg, 1 mmol) with H 2 O (cat) (100 mL) were added and the resulting homogeneous solution was vigorously stirred for 24 h at the ambient temperature while the progress was monitored by NMR spectroscopy. Aer the reaction was completed the solvent was evaporated and the remaining residue was dissolved in EtOAc (50 mL). Organic phase was ltered through anhydrous Na 2 SO 4 pad and concentrated to yield Boc-1-H as a white powder (94%, 3.8 g 5, 159.8, 155.7, 103.8, 78.3, 35.5, 28.2. Anal. calcd for C 9 H 14 N 2 O 3 : C, 54.53; H, 7.12; N, 14.13. Found: C, 54.36; H, 7.18; N, 14. 01.
Synthesis of the ABT-418 bioisostere 16
tert-Butyl (2S)-2-(5-(bromomethyl)-4,5-dihydroisoxazol-3-yl) pyrrolidine-1-carboxylate (13). A 500 mL round bottomed ask was charged with a magnetic stirrer, corresponding chloroxime 4 (10 g, 40.2 mmol) and EtOAc (100 mL). To the resulting vigorously stirred homogeneous solution allyl bromide (5.6 g, 46.23 mmol) was added followed by addition of NaHCO 3 (6.7 g, 80.4 mmol) . The resulting mixture was stirred overnight. The progress of the reaction was monitored by NMR spectroscopy. Aer the reaction was complete, organic phase was dried over anhydrous Na 2 SO 4 and ltered through the silica gel pad. The resulting solution was concentrated to yield 13 (95%, 12.95 g) as a white powder, mp 60 C. 3, 159.7, 153.5, 153.1, 78.8, 78.3, 54.0, 46.3, 46.0, 38.7, 35.7, 35.2, 34.8, 30.4, 30.2, 29.6, 29.3, 28.0, 23.9, 23. , 6.35; N, 8.41. Found: C, 46.77; H, 6.44; N, 8.57 . tert-Butyl (S)-2-(5-methylisoxazol-3-yl)pyrrolidine-1-carboxylate (14) . A 250 mL round bottomed ask was charged with a magnetic stirrer, corresponding isoxazoline 13 (12.5 g, 37.5 mmol) and DMF (50 mL). K 2 CO 3 (10.4 g, 75 mmol) was added and the resulting mixture was stirred overnight at 100 C. The progress of the reaction was monitored by NMR spectroscopy.
13-S-
Aer the reaction was complete, the reaction mixture was concentrated the residue was poured into ice-bath and aqueous phase was extracted with EtOAc. The combined orhanic phases were washed with brine (4 Â 20 mL). Organic phase was dried over anhydrous Na 2 SO 4 . The resulting mixture was ltered through the silicagel pad and the solution was concentrated. The residue is colorless oil which was solidied upon standing 77%. 166.4, 166.0, 153.5, 153.2, 100.4, 99.8, 78.6, 78.5, 53.3, 53.1, 46.3, 46.0, 32.6, 31.3, 28.1, 27.9, 23.6, 22.9, 11.7 , 6.95; N, 14.85. Found: C, 50.87; H, 7.08; N, 14.89 . (S)-5-Methyl-3-(1-methylpyrrolidin-2-yl)isoxazole (16) . A 500 mL round bottomed ask was charged with magnetic stirrer and corresponding isoxazole 15 (2.1 g, 10.60 mmol) which was suspended in dichloroethane (250 mL). MeOH (50 mL) was added followed by addition of 30% CH 2 O (aq) (10 mL) and NaBH(OAC) 3 (7.0 g, 33.03 mmol) . Then, the resulting mixture was stirred overnight at the ambient temperature. Next, the reaction mixture was concentrated, EtOAc (250 mL) was added and K 2 CO 3 was added until the pH ¼ 10 was reached (Caution: carbon dioxide evolution!). The reaction mixture was then stirred over Na 2 SO 4 for ca. 10 min ltered and concentrated. The product was puried by distillation yielding 16 (1.52 g, bp 75-80 C at 5.5 mmHg) as a colorless liquid (with pyrrolidine odour) which is extremely well soluble in water. H, 8.49; N, 16.85. Found: C, 65.14; H, 8.33; N, 16.94. Notes and references
14-S-
